These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 24697305

  • 21. Phototherapy for mycosis fungoides.
    Dogra S, Mahajan R.
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [Abstract] [Full Text] [Related]

  • 22. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN, Neckel SL, Oberhelman L, Anderson TF, Cooper KD.
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [Abstract] [Full Text] [Related]

  • 23. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
    Herrmann JJ, Roenigk HH, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, Rosen ST.
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):234-42. PubMed ID: 7622650
    [Abstract] [Full Text] [Related]

  • 24. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
    Phan K, Ramachandran V, Fassihi H, Sebaratnam DF.
    JAMA Dermatol; 2019 Mar 01; 155(3):335-341. PubMed ID: 30698622
    [Abstract] [Full Text] [Related]

  • 25. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R.
    J Am Acad Dermatol; 2003 Jul 01; 49(1):35-49. PubMed ID: 12833006
    [Abstract] [Full Text] [Related]

  • 26. [Combined therapy of psoralen plus ultraviolet A followed by narrow band ultraviolet B photochemotherapy for early stage mycosis fungoides].
    Wang T, Liu Y, Zheng H, Zuo Y, Fang K.
    Zhonghua Zhong Liu Za Zhi; 2014 Aug 01; 36(8):626-8. PubMed ID: 25430032
    [Abstract] [Full Text] [Related]

  • 27. The efficacy of long-term psoralen plus ultraviolet A and low-dose interferon-a combination therapy in mycosis fungoides: A literature review.
    Şanlı H, Yıldızhan İK, Gündüz K, Akay BN.
    Photodermatol Photoimmunol Photomed; 2024 Jul 01; 40(4):e12991. PubMed ID: 39046175
    [Abstract] [Full Text] [Related]

  • 28. Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.
    Rupoli S, Barulli S, Guiducci B, Offidani M, Mozzicafreddo G, Simonacci M, Filosa G, Giacchetti A, Ricotti G, Brandozzi G, Cataldi I, Serresi S, Ceschini R, Bugatti L, Offidani A, Giangiacomi M, Brancorsini D, Leoni P.
    Haematologica; 1999 Sep 01; 84(9):809-13. PubMed ID: 10477454
    [Abstract] [Full Text] [Related]

  • 29. Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic.
    Grandi V, Delfino C, Pileri A, Pimpinelli N.
    Br J Dermatol; 2017 Aug 01; 177(2):406-410. PubMed ID: 28078669
    [Abstract] [Full Text] [Related]

  • 30. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S, Vaid R, Aladily TN, Ivan DS, Talpur R, Duvic M.
    J Am Acad Dermatol; 2014 Dec 01; 71(6):1117-26. PubMed ID: 25264240
    [Abstract] [Full Text] [Related]

  • 31. Excimer laser in the treatment of mycosis fungoides.
    Deaver D, Cauthen A, Cohen G, Sokol L, Glass F.
    J Am Acad Dermatol; 2014 Jun 01; 70(6):1058-60. PubMed ID: 24775402
    [Abstract] [Full Text] [Related]

  • 32. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L, Truc G, Dalac S, Lambert D, Petrella T, Barillot I, Naudy S, Horiot JC, Maingon P.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1128-34. PubMed ID: 15001254
    [Abstract] [Full Text] [Related]

  • 33. PUVA-induced pityriasis lichenoides chronica-like papular lesions in patients with mycosis fungoides: a clinical, histopathological and immunohistochemical study.
    Youssef R, Abdel-Halim MRE, Abdel Halim DM, Fawzy MM, Hussein MF, Elmasry MF, Sayed SS, Abo Eid NM.
    Arch Dermatol Res; 2019 Nov 15; 311(9):673-678. PubMed ID: 31300833
    [Abstract] [Full Text] [Related]

  • 34. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M, García-Arpa M, González-García J.
    Int J Dermatol; 2007 Jan 15; 46(1):99-102. PubMed ID: 17214731
    [Abstract] [Full Text] [Related]

  • 35. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K, Hammar H, Molin L, Volden G.
    Acta Derm Venereol; 1989 Jan 15; 69(6):536-8. PubMed ID: 2575334
    [Abstract] [Full Text] [Related]

  • 36. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb 15; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [Abstract] [Full Text] [Related]

  • 37. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
    Roberge D, Muanza T, Blake G, Shustik C, Vuong T, Freeman CR.
    Br J Dermatol; 2007 Jan 15; 156(1):57-61. PubMed ID: 17199567
    [Abstract] [Full Text] [Related]

  • 38. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul 15; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 39. Bcl-2 expression in mycosis fungoides before and after PUVA therapy.
    Weshahy H, Mahgoub D, El-Eishy N, El-Tawdy AM, Bassiouny DA, Hunter N, Hindawi A.
    Photodermatol Photoimmunol Photomed; 2010 Apr 15; 26(2):107-9. PubMed ID: 20415745
    [Abstract] [Full Text] [Related]

  • 40. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread.
    Roupe G, Sandström MH, Kjellström C.
    Acta Derm Venereol; 1996 Nov 15; 76(6):475-8. PubMed ID: 8982416
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.